Articles

A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma)

Clinical Division of Oncology, Department of Internal Medicine I and the Comprehensive Cancer Center of the Medical University Vienna, Vienna, Austria
Clinical Division of Oncology, Department of Internal Medicine I and the Comprehensive Cancer Center of the Medical University Vienna, Vienna, Austria
Clinical Division of Gastroenterology, Department of Internal Medicine III and the Comprehensive Cancer Center of the Medical University Vienna, Vienna, Austria
Department of Pathology and
Department of Ophthalmology and the Comprehensive Cancer Center of the Medical University Vienna, Vienna, Austria
Clinical Division of Oncology, Department of Internal Medicine I and the Comprehensive Cancer Center of the Medical University Vienna, Vienna, Austria
Clinical Division of Oncology, Department of Internal Medicine I and the Comprehensive Cancer Center of the Medical University Vienna, Vienna, Austria
Vol. 98 No. 3 (2013): March, 2013 https://doi.org/10.3324/haematol.2012.065995